- Report
- May 2024
- 130 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Report
- May 2024
- 138 Pages
Global
From €5930EUR$6,499USD£5,039GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €456EUR$500USD£388GBP
Multaq is a cardiovascular drug used to treat atrial fibrillation and atrial flutter. It is a class III antiarrhythmic drug, meaning it works by blocking certain electrical signals in the heart that cause irregular heartbeats. Multaq is used to reduce the risk of stroke and other cardiovascular events in patients with atrial fibrillation or atrial flutter. It is also used to reduce the frequency of episodes of atrial fibrillation or atrial flutter.
Multaq is available in both generic and brand-name formulations. The brand-name formulation is manufactured by Sanofi-Aventis, while the generic formulation is manufactured by several generic drug companies. Some of the companies that manufacture generic Multaq include Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more